Since COTI-2 has activity in both tumor cells carrying mutant TP53 and wtp53 and inhibits the PI3K-AKT pathway[89], the exact role of mutp53 reactivation in COTI-2-induced tumor cell death remains unclear. This evidence concerns the gene TP53 and neoplasm.